Infectious virions

Infection is established Viral genes expressed Viral genome replicated Production of infectious virions blocked No protection from CPE No protection from CTL No selective advantage... 

In 1995, HlV-1 latency was first documented in HIV-1-infected patients when ex vivo T cell cultures were found to contain a subpopulation of cells that produced infectious virions when stimulated with T cell activators (Chun et al. 1995 Finzi et al. 1997). Latently infected T cells are rare, to the order of one in a million resting... 

On the other hand, this procedure does not remove virus-specific components from the liquid. Even in cases where virions are destroyed completely following treatment, the product will remain immunogenic to the same extent as before the treatment. Nevertheless, no infectious virions able to reproduce, multiply, and cause an infectious disease will be found in the product. 

The diminution in infectivity could be caused either by the production of virus particles having a lessened or abolished infectivity, or a decreased formation of infectious virions. The envelope glycoproteins of Semliki Forest virus and Sindbis virus synthesized in the presence of tunicamycin (and, thus, devoid of carbohydrate) are metabolically stable. They do not participate in the assembly of virus particles, although nucleocapsids are still formed under these conditions and are... 

It is possible to use ODVs as a source of infectious virions if they are released from the OBs using alkaline solutions. But when OBs are dissolved in alkaline solution before infection of cell lines, there is only a low level of in vitro activity (Vail et al., 1979 Elam et al., 1990). However, this process can be improved by using proteinases. McIntosh et al. (1988) achieved an improvement in the insect cell culture susceptibility to ODVs using a treatment with proteinase K to dissolve Helicoverpa zea NPV (HzSNPV) polyhedra, which could infect homologous cells. Lynn (1994) also achieved the same result when he used a treatment of dissolving Lymantria dispar NPV (LdMNPV) polyhedra with trypsin. 

All herpesvirus virions have a characteristic appearance (Fig. ID) with an icosahedral capsid surrounded by a thick ( 500 A) layer of protein designated the tegument (Rixon, 1993 Steven and Spear, 1997). The entire particle is enclosed by a spherical lipid envelope (Szilagyi and Berriman, 1994). The core of infectious virions is believed to consist exclusively of the double-stranded DNA genome without any associated protein (Booy et al, 1991 Zhou et al, 1999). The structures of the tegument and envelope are poorly understood as they are indeterminate in both size and composition and have a limited symmetrical relationship to the capsid (Chen et al, 1999 Zhou et al, 1999). 

Alternatively, endothelial cells and astrocytes (which compose the blood-brain banier) are infected directly (Strelow et al., 2001). A valiant of this theory is that infectious virions are transported in the cytoplasm of astrocytes and endothelial cells, and eventually transfeired to central nervous system cells by trans-cytosis or macropynocytosis) (Marechal et al., 2001). 

Later in the life cycle during the process of budding, the enzyme HIV protease cleaves the polyproteins in the core, converting the immature viral particles into infectious virions. Protease inhibitors (Pis) inhibit the viral protease enzyme to prevent cleavage of the polyproteins so that... 

Table 1. Applied parameter set and initial conditions (note, that not every virus particle is infectious and non infectious virions have to be considered)...

Sells, M. A., Zelent, A. Z., Shvartsman, M., and Acs, G. (1988) Replication intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62, 2836-2844. 

Fig. 2.4 Flowchart of the steps for rAAV production as described in Protocol 1. HEK293 cells are expanded, transfected, and harvested at 60h posttransfection. The cells are lysed, and loaded onto either a cesium chloride gradient or an iodixanol gradient to separate infectious virions from empty capsids. Virus is purified using either heparin affinity chromatography or ion-exchange chromatography. Virus preparations are formulated and concentrated, and characterized...

Viral dynamic modeling has been described for the effects of two classes of anti-HIV drugs, namely, reverse-transcriptase inhibitors (RTIs) that prevent infection of new cells and protease inhibitors (Pis) that decrease production of infectious virions by blocking the release of virions from infected cells, leading to the production of... 

Drug resistance is also an extensive and serious problem. Because of the high mutation rate of HIV and the tremendous number of infectious virions, there is a high likelihood that any infected individual will harbor viruses with single-amino-acid mutations conferring some degree of resistance... 

The human immunodeficiency virus protease (HIV-PR), an aspartic acid protease, is involved in the processing of viral polyproteins and is therefore essential for the production of new infectious virions. This enzyme is one of the best-characterized macromolecules from the vantage of drug design, with several hundred crystal structures determined to date. Protein crystallography has contributed in many... 

Mechanisms Indinavir inhibits HIV-1 protease, an enzyme that cleaves viral precursor proteins and is critical to the production of mature infectious virions. The protease is encoded by the pol gene, and resistance to indinavir is mediated by multiple point mutations. Up to 70% of indinavir-resistant strains are cross-resistant with ritonavir. 

Indinavir is a specific inhibitor of HIV-1 protease which is essential for the production of mature and infectious virions. It is currently clinically approved for treatment of HIV-1 infections. 

Methisazone does not interfere with the replication of viral DNA, the synthesis of viral mRNA, or the functioning of early viral mRNA. However, by disorganizing the formation of late proteins, it prevents assembly of complete, infectious virions (Prusoff, 1967). The antiviral spectrum of this drug is wide, in vitro. It inhibits multiplication of all pox-viruses, and other DNA viruses too (e.g. the adenoviruses and varicella), as well as several groups of RNA viruses (e.g. poliomyelitis, common cold, influenza A and B, and some arboviruses). However, in Man, no benefit can be demonstrated in these diseases at any dose that does not cause intense nausea and vomiting (Turner, Bauer and Nimmo-Smith, 1962). 

---